chr9-121822717-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001139442.2(TTLL11):c.2003C>T(p.Ser668Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000193 in 1,398,576 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001139442.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TTLL11 | NM_001139442.2 | c.2003C>T | p.Ser668Leu | missense_variant | 9/9 | ENST00000321582.11 | NP_001132914.2 | |
TTLL11 | NM_001386833.1 | c.350C>T | p.Ser117Leu | missense_variant | 4/4 | NP_001373762.1 | ||
TTLL11 | XM_047422825.1 | c.1427C>T | p.Ser476Leu | missense_variant | 8/8 | XP_047278781.1 | ||
TTLL11 | XR_001746188.2 | n.2163C>T | non_coding_transcript_exon_variant | 9/10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TTLL11 | ENST00000321582.11 | c.2003C>T | p.Ser668Leu | missense_variant | 9/9 | 5 | NM_001139442.2 | ENSP00000321346.6 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000327 AC: 5AN: 152910Hom.: 0 AF XY: 0.0000492 AC XY: 4AN XY: 81332
GnomAD4 exome AF: 0.0000193 AC: 27AN: 1398576Hom.: 0 Cov.: 32 AF XY: 0.0000232 AC XY: 16AN XY: 689788
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 09, 2021 | The c.2273C>T (p.S758L) alteration is located in exon 9 (coding exon 9) of the TTLL11 gene. This alteration results from a C to T substitution at nucleotide position 2273, causing the serine (S) at amino acid position 758 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at